APO Research

APO RESEARCH · REPORT

Hospital Infection Management System

Selected research

Market Outlook & Growth Opportunities

Global Hospital Infection Management System Market Outlook and Growth Opportunities 2026

Market perspective

The global Hospital Infection Management System market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Hospital Infection Management System is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Hospital Infection Management System is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Hospital Infection Management System is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Hospital Infection Management System market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Hospital Infection Management System market include Laoken Medical, STERIS, DNV, Huawei, Dräger, Ecolab, Yinjiang Technology, Yi Ou Technology and Zexin Software, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Hospital Infection Management System market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Hospital Infection Management System and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Hospital Infection Management System revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Hospital Infection Management System market.

Hospital Infection Management System Segment by Company

Laoken Medical

STERIS

DNV

Huawei

Dräger

Ecolab

Yinjiang Technology

Yi Ou Technology

Zexin Software

Siyunshan Technology

Ganxin Information Technology

Peking University Medical Information Technology

Hospital Infection Management System Segment by Type

Endogenous Infection Type

Exogenous Infectious Type

Hospital Infection Management System Segment by Application

Public Hospital

Private Hospital

Hospital Infection Management System Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Hospital Infection Management System status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Hospital Infection Management System key companies, revenue, market share, and recent developments.

3. To split the Hospital Infection Management System breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Hospital Infection Management System market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Hospital Infection Management System significant trends, drivers, influence factors in global and regions.

6. To analyze Hospital Infection Management System competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Hospital Infection Management System market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Hospital Infection Management System and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Hospital Infection Management System.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Hospital Infection Management System industry.

Chapter 3: Detailed analysis of Hospital Infection Management System company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Hospital Infection Management System in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Hospital Infection Management System in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Hospital Infection Management System Industry Trends Table 2. Hospital Infection Management System Industry Drivers Table 3. Hospital Infection Management System Industry Opportunities and Challenges Table 4. Hospital Infection Management System Industry Restraints Table 5. Global Hospital Infection Management System Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Hospital Infection Management System Revenue Share by Company (2021-2026) Table 7. Global Hospital Infection Management System Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Hospital Infection Management System Key Company Manufacturing Base & Headquarters Table 9. Global Hospital Infection Management System Company, Product Type & Application Table 10. Global Hospital Infection Management System Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Hospital Infection Management System by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Endogenous Infection Type Table 15. Significant Companies of Exogenous Infectious Type Table 16. Global Hospital Infection Management System Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 17. Global Hospital Infection Management System Sales Value by Type (2021-2026) & (US$ Million) Table 18. Global Hospital Infection Management System Sales Value by Type (2027-2032) & (US$ Million) Table 19. Global Hospital Infection Management System Sales Value Share by Type (2021-2026) Table 20. Global Hospital Infection Management System Sales Value Share by Type (2027-2032) Table 21. Significant Companies of Public Hospital Table 22. Significant Companies of Private Hospital Table 23. Global Hospital Infection Management System Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 24. Global Hospital Infection Management System Sales Value by Application (2021-2026) & (US$ Million) Table 25. Global Hospital Infection Management System Sales Value by Application (2027-2032) & (US$ Million) Table 26. Global Hospital Infection Management System Sales Value Share by Application (2021-2026) Table 27. Global Hospital Infection Management System Sales Value Share by Application (2027-2032) Table 28. Global Hospital Infection Management System Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 29. Global Hospital Infection Management System Sales Value by Region (2021-2026) & (US$ Million) Table 30. Global Hospital Infection Management System Sales Value Share by Region (2021-2026) Table 31. Global Hospital Infection Management System Sales Value by Region (2027-2032) & (US$ Million) Table 32. Global Hospital Infection Management System Sales Value Share by Region (2027-2032) Table 33. Global Hospital Infection Management System Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Hospital Infection Management System Sales Value by Country (2021-2026) & (US$ Million) Table 35. Global Hospital Infection Management System Sales Value Market Share by Country (2021-2026) Table 36. Global Hospital Infection Management System Sales Value by Country (2027-2032) & (US$ Million) Table 37. Global Hospital Infection Management System Sales Value Market Share by Country (2027-2032) Table 38. Laoken Medical Company Information Table 39. Laoken Medical Business Overview Table 40. Laoken Medical Hospital Infection Management System Revenue (US$ Million) and Gross Margin (2021-2026) Table 41. Laoken Medical Hospital Infection Management System Product Portfolio Table 42. Laoken Medical Recent Development Table 43. STERIS Company Information Table 44. STERIS Business Overview Table 45. STERIS Hospital Infection Management System Revenue (US$ Million) and Gross Margin (2021-2026) Table 46. STERIS Hospital Infection Management System Product Portfolio Table 47. STERIS Recent Development Table 48. DNV Company Information Table 49. DNV Business Overview Table 50. DNV Hospital Infection Management System Revenue (US$ Million) and Gross Margin (2021-2026) Table 51. DNV Hospital Infection Management System Product Portfolio Table 52. DNV Recent Development Table 53. Huawei Company Information Table 54. Huawei Business Overview Table 55. Huawei Hospital Infection Management System Revenue (US$ Million) and Gross Margin (2021-2026) Table 56. Huawei Hospital Infection Management System Product Portfolio Table 57. Huawei Recent Development Table 58. Dräger Company Information Table 59. Dräger Business Overview Table 60. Dräger Hospital Infection Management System Revenue (US$ Million) and Gross Margin (2021-2026) Table 61. Dräger Hospital Infection Management System Product Portfolio Table 62. Dräger Recent Development Table 63. Ecolab Company Information Table 64. Ecolab Business Overview Table 65. Ecolab Hospital Infection Management System Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. Ecolab Hospital Infection Management System Product Portfolio Table 67. Ecolab Recent Development Table 68. Yinjiang Technology Company Information Table 69. Yinjiang Technology Business Overview Table 70. Yinjiang Technology Hospital Infection Management System Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. Yinjiang Technology Hospital Infection Management System Product Portfolio Table 72. Yinjiang Technology Recent Development Table 73. Yi Ou Technology Company Information Table 74. Yi Ou Technology Business Overview Table 75. Yi Ou Technology Hospital Infection Management System Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. Yi Ou Technology Hospital Infection Management System Product Portfolio Table 77. Yi Ou Technology Recent Development Table 78. Zexin Software Company Information Table 79. Zexin Software Business Overview Table 80. Zexin Software Hospital Infection Management System Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. Zexin Software Hospital Infection Management System Product Portfolio Table 82. Zexin Software Recent Development Table 83. Siyunshan Technology Company Information Table 84. Siyunshan Technology Business Overview Table 85. Siyunshan Technology Hospital Infection Management System Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. Siyunshan Technology Hospital Infection Management System Product Portfolio Table 87. Siyunshan Technology Recent Development Table 88. Ganxin Information Technology Company Information Table 89. Ganxin Information Technology Business Overview Table 90. Ganxin Information Technology Hospital Infection Management System Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 91. Ganxin Information Technology Hospital Infection Management System Product Portfolio Table 92. Ganxin Information Technology Recent Development Table 93. Peking University Medical Information Technology Company Information Table 94. Peking University Medical Information Technology Business Overview Table 95. Peking University Medical Information Technology Hospital Infection Management System Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 96. Peking University Medical Information Technology Hospital Infection Management System Product Portfolio Table 97. Peking University Medical Information Technology Recent Development Table 98. Research Programs/Design for This Report Table 99. Authors List of This Report Table 100. Secondary Sources Table 101. Primary Sources List of Figures Figure 1. Hospital Infection Management System Product Image Figure 2. Global Hospital Infection Management System Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Hospital Infection Management System Market Size (2021-2032) & (US$ Million) Figure 4. Global Hospital Infection Management System Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Endogenous Infection Type Image Figure 8. Exogenous Infectious Type Image Figure 9. Global Hospital Infection Management System Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 10. Global Hospital Infection Management System Sales Value Share 2021 VS 2025 VS 2032 Figure 11. Global Hospital Infection Management System Sales Value Share by Type (2021-2032) Figure 12. Public Hospital Image Figure 13. Private Hospital Image Figure 14. Global Hospital Infection Management System Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Hospital Infection Management System Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Hospital Infection Management System Sales Value Share by Application (2021-2032) Figure 17. Global Hospital Infection Management System Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 18. Global Hospital Infection Management System Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 19. North America Hospital Infection Management System Sales Value (2021-2032) & (US$ Million) Figure 20. North America Hospital Infection Management System Sales Value Share by Country (%), 2025 VS 2032 Figure 21. Europe Hospital Infection Management System Sales Value (2021-2032) & (US$ Million) Figure 22. Europe Hospital Infection Management System Sales Value Share by Country (%), 2025 VS 2032 Figure 23. Asia-Pacific Hospital Infection Management System Sales Value (2021-2032) & (US$ Million) Figure 24. Asia-Pacific Hospital Infection Management System Sales Value Share by Country (%), 2025 VS 2032 Figure 25. South America Hospital Infection Management System Sales Value (2021-2032) & (US$ Million) Figure 26. South America Hospital Infection Management System Sales Value Share by Country (%), 2025 VS 2032 Figure 27. Middle East & Africa Hospital Infection Management System Sales Value (2021-2032) & (US$ Million) Figure 28. Middle East & Africa Hospital Infection Management System Sales Value Share by Country (%), 2025 VS 2032 Figure 29. USA Hospital Infection Management System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 30. USA Hospital Infection Management System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 31. USA Hospital Infection Management System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 32. Canada Hospital Infection Management System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 33. Canada Hospital Infection Management System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 34. Canada Hospital Infection Management System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 35. Mexico Hospital Infection Management System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 36. Mexico Hospital Infection Management System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 37. Mexico Hospital Infection Management System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 38. Germany Hospital Infection Management System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 39. Germany Hospital Infection Management System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 40. Germany Hospital Infection Management System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 41. France Hospital Infection Management System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. France Hospital Infection Management System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. France Hospital Infection Management System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. U.K. Hospital Infection Management System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. U.K. Hospital Infection Management System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. U.K. Hospital Infection Management System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. Italy Hospital Infection Management System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. Italy Hospital Infection Management System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. Italy Hospital Infection Management System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Spain Hospital Infection Management System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Spain Hospital Infection Management System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Spain Hospital Infection Management System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. Russia Hospital Infection Management System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. Russia Hospital Infection Management System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. Russia Hospital Infection Management System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. Netherlands Hospital Infection Management System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. Netherlands Hospital Infection Management System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. Netherlands Hospital Infection Management System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Nordic Countries Hospital Infection Management System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Nordic Countries Hospital Infection Management System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Nordic Countries Hospital Infection Management System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. China Hospital Infection Management System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. China Hospital Infection Management System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. China Hospital Infection Management System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Japan Hospital Infection Management System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Japan Hospital Infection Management System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Japan Hospital Infection Management System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. South Korea Hospital Infection Management System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. South Korea Hospital Infection Management System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. South Korea Hospital Infection Management System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. India Hospital Infection Management System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. India Hospital Infection Management System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. India Hospital Infection Management System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. Australia Hospital Infection Management System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. Australia Hospital Infection Management System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. Australia Hospital Infection Management System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Southeast Asia Hospital Infection Management System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Southeast Asia Hospital Infection Management System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Southeast Asia Hospital Infection Management System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. Brazil Hospital Infection Management System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. Brazil Hospital Infection Management System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. Brazil Hospital Infection Management System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. Argentina Hospital Infection Management System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. Argentina Hospital Infection Management System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. Argentina Hospital Infection Management System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Chile Hospital Infection Management System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Chile Hospital Infection Management System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Chile Hospital Infection Management System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Colombia Hospital Infection Management System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Colombia Hospital Infection Management System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Colombia Hospital Infection Management System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Peru Hospital Infection Management System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Peru Hospital Infection Management System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Peru Hospital Infection Management System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Saudi Arabia Hospital Infection Management System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Saudi Arabia Hospital Infection Management System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Saudi Arabia Hospital Infection Management System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Israel Hospital Infection Management System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Israel Hospital Infection Management System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Israel Hospital Infection Management System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. UAE Hospital Infection Management System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. UAE Hospital Infection Management System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. UAE Hospital Infection Management System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Turkey Hospital Infection Management System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Turkey Hospital Infection Management System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Turkey Hospital Infection Management System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Iran Hospital Infection Management System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Iran Hospital Infection Management System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Iran Hospital Infection Management System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Egypt Hospital Infection Management System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Egypt Hospital Infection Management System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Egypt Hospital Infection Management System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. Years Considered Figure 114. Research Process Figure 115. Key Executives Interviewed

Scope & coverage.

Types
  • Endogenous Infection Type
  • Exogenous Infectious Type
Applications
  • Public Hospital
  • Private Hospital
Companies covered
  • Laoken Medical
  • STERIS
  • DNV
  • Huawei
  • Dräger
  • Ecolab
  • Yinjiang Technology
  • Yi Ou Technology
  • Zexin Software
  • Siyunshan Technology
  • Ganxin Information Technology
  • Peking University Medical Information Technology

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Hospital Infection Management System Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Hospital Infection Management System Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Hospital Infection Management System Market Dynamics
  1. 2.1 Hospital Infection Management System Industry Trends
  2. 2.2 Hospital Infection Management System Industry Drivers
  3. 2.3 Hospital Infection Management System Industry Opportunities and Challenges
  4. 2.4 Hospital Infection Management System Industry Restraints
3 Hospital Infection Management System Market by Company
  1. 3.1 Global Hospital Infection Management System Company Revenue Ranking in 2025
  2. 3.2 Global Hospital Infection Management System Revenue by Company (2021-2026)
  3. 3.3 Global Hospital Infection Management System Company Ranking (2024-2026)
  4. 3.4 Global Hospital Infection Management System Company Manufacturing Base and Headquarters
  5. 3.5 Global Hospital Infection Management System Company Product Type and Application
  6. 3.6 Global Hospital Infection Management System Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Hospital Infection Management System Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Hospital Infection Management System Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Hospital Infection Management System Market by Type
  1. 4.1 Hospital Infection Management System Type Introduction
  2. 4.1.1 Endogenous Infection Type
  3. 4.1.2 Exogenous Infectious Type
  4. 4.2 Global Hospital Infection Management System Sales Value by Type
  5. 4.2.1 Global Hospital Infection Management System Sales Value by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Hospital Infection Management System Sales Value by Type (2021-2032)
  7. 4.2.3 Global Hospital Infection Management System Sales Value Share by Type (2021-2032)
5 Hospital Infection Management System Market by Application
  1. 5.1 Hospital Infection Management System Application Introduction
  2. 5.1.1 Public Hospital
  3. 5.1.2 Private Hospital
  4. 5.2 Global Hospital Infection Management System Sales Value by Application
  5. 5.2.1 Global Hospital Infection Management System Sales Value by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Hospital Infection Management System Sales Value by Application (2021-2032)
  7. 5.2.3 Global Hospital Infection Management System Sales Value Share by Application (2021-2032)
6 Hospital Infection Management System Regional Value Analysis
  1. 6.1 Global Hospital Infection Management System Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Hospital Infection Management System Sales Value by Region (2021-2032)
  3. 6.2.1 Global Hospital Infection Management System Sales Value by Region: 2021-2026
  4. 6.2.2 Global Hospital Infection Management System Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Hospital Infection Management System Sales Value (2021-2032)
  7. 6.3.2 North America Hospital Infection Management System Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Hospital Infection Management System Sales Value (2021-2032)
  10. 6.4.2 Europe Hospital Infection Management System Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Hospital Infection Management System Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Hospital Infection Management System Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Hospital Infection Management System Sales Value (2021-2032)
  16. 6.6.2 South America Hospital Infection Management System Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Hospital Infection Management System Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Hospital Infection Management System Sales Value Share by Country, 2025 VS 2032
7 Hospital Infection Management System Country-level Value Analysis
  1. 7.1 Global Hospital Infection Management System Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Hospital Infection Management System Sales Value by Country (2021-2032)
  3. 7.2.1 Global Hospital Infection Management System Sales Value by Country (2021-2026)
  4. 7.2.2 Global Hospital Infection Management System Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Hospital Infection Management System Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Hospital Infection Management System Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Hospital Infection Management System Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Hospital Infection Management System Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Hospital Infection Management System Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Hospital Infection Management System Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Hospital Infection Management System Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Hospital Infection Management System Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Hospital Infection Management System Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Hospital Infection Management System Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Hospital Infection Management System Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Hospital Infection Management System Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Hospital Infection Management System Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Hospital Infection Management System Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Hospital Infection Management System Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Hospital Infection Management System Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Hospital Infection Management System Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Hospital Infection Management System Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Hospital Infection Management System Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Hospital Infection Management System Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Hospital Infection Management System Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Hospital Infection Management System Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Hospital Infection Management System Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Hospital Infection Management System Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Hospital Infection Management System Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Hospital Infection Management System Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Hospital Infection Management System Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Hospital Infection Management System Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Hospital Infection Management System Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Hospital Infection Management System Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Hospital Infection Management System Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Hospital Infection Management System Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Hospital Infection Management System Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Hospital Infection Management System Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Hospital Infection Management System Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Hospital Infection Management System Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Hospital Infection Management System Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Hospital Infection Management System Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Hospital Infection Management System Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Hospital Infection Management System Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Hospital Infection Management System Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Hospital Infection Management System Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Hospital Infection Management System Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Hospital Infection Management System Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Hospital Infection Management System Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Hospital Infection Management System Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Hospital Infection Management System Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Hospital Infection Management System Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Hospital Infection Management System Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Hospital Infection Management System Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Hospital Infection Management System Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Hospital Infection Management System Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Hospital Infection Management System Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Hospital Infection Management System Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Hospital Infection Management System Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Hospital Infection Management System Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Hospital Infection Management System Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Hospital Infection Management System Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Hospital Infection Management System Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Hospital Infection Management System Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Hospital Infection Management System Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Hospital Infection Management System Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Hospital Infection Management System Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Hospital Infection Management System Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Hospital Infection Management System Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Hospital Infection Management System Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Hospital Infection Management System Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Hospital Infection Management System Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Hospital Infection Management System Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Hospital Infection Management System Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Hospital Infection Management System Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Hospital Infection Management System Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Hospital Infection Management System Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Hospital Infection Management System Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Hospital Infection Management System Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Hospital Infection Management System Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Hospital Infection Management System Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Hospital Infection Management System Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Hospital Infection Management System Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Hospital Infection Management System Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Hospital Infection Management System Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Hospital Infection Management System Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Hospital Infection Management System Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Hospital Infection Management System Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Laoken Medical
  2. 8.1.1 Laoken Medical Company Information
  3. 8.1.2 Laoken Medical Business Overview
  4. 8.1.3 Laoken Medical Hospital Infection Management System Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Laoken Medical Hospital Infection Management System Product Portfolio
  6. 8.1.5 Laoken Medical Recent Developments
  7. 8.2 STERIS
  8. 8.2.1 STERIS Company Information
  9. 8.2.2 STERIS Business Overview
  10. 8.2.3 STERIS Hospital Infection Management System Revenue and Gross Margin (2021-2026)
  11. 8.2.4 STERIS Hospital Infection Management System Product Portfolio
  12. 8.2.5 STERIS Recent Developments
  13. 8.3 DNV
  14. 8.3.1 DNV Company Information
  15. 8.3.2 DNV Business Overview
  16. 8.3.3 DNV Hospital Infection Management System Revenue and Gross Margin (2021-2026)
  17. 8.3.4 DNV Hospital Infection Management System Product Portfolio
  18. 8.3.5 DNV Recent Developments
  19. 8.4 Huawei
  20. 8.4.1 Huawei Company Information
  21. 8.4.2 Huawei Business Overview
  22. 8.4.3 Huawei Hospital Infection Management System Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Huawei Hospital Infection Management System Product Portfolio
  24. 8.4.5 Huawei Recent Developments
  25. 8.5 Dräger
  26. 8.5.1 Dräger Company Information
  27. 8.5.2 Dräger Business Overview
  28. 8.5.3 Dräger Hospital Infection Management System Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Dräger Hospital Infection Management System Product Portfolio
  30. 8.5.5 Dräger Recent Developments
  31. 8.6 Ecolab
  32. 8.6.1 Ecolab Company Information
  33. 8.6.2 Ecolab Business Overview
  34. 8.6.3 Ecolab Hospital Infection Management System Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Ecolab Hospital Infection Management System Product Portfolio
  36. 8.6.5 Ecolab Recent Developments
  37. 8.7 Yinjiang Technology
  38. 8.7.1 Yinjiang Technology Company Information
  39. 8.7.2 Yinjiang Technology Business Overview
  40. 8.7.3 Yinjiang Technology Hospital Infection Management System Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Yinjiang Technology Hospital Infection Management System Product Portfolio
  42. 8.7.5 Yinjiang Technology Recent Developments
  43. 8.8 Yi Ou Technology
  44. 8.8.1 Yi Ou Technology Company Information
  45. 8.8.2 Yi Ou Technology Business Overview
  46. 8.8.3 Yi Ou Technology Hospital Infection Management System Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Yi Ou Technology Hospital Infection Management System Product Portfolio
  48. 8.8.5 Yi Ou Technology Recent Developments
  49. 8.9 Zexin Software
  50. 8.9.1 Zexin Software Company Information
  51. 8.9.2 Zexin Software Business Overview
  52. 8.9.3 Zexin Software Hospital Infection Management System Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Zexin Software Hospital Infection Management System Product Portfolio
  54. 8.9.5 Zexin Software Recent Developments
  55. 8.10 Siyunshan Technology
  56. 8.10.1 Siyunshan Technology Company Information
  57. 8.10.2 Siyunshan Technology Business Overview
  58. 8.10.3 Siyunshan Technology Hospital Infection Management System Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Siyunshan Technology Hospital Infection Management System Product Portfolio
  60. 8.10.5 Siyunshan Technology Recent Developments
  61. 8.11 Ganxin Information Technology
  62. 8.11.1 Ganxin Information Technology Company Information
  63. 8.11.2 Ganxin Information Technology Business Overview
  64. 8.11.3 Ganxin Information Technology Hospital Infection Management System Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Ganxin Information Technology Hospital Infection Management System Product Portfolio
  66. 8.11.5 Ganxin Information Technology Recent Developments
  67. 8.12 Peking University Medical Information Technology
  68. 8.12.1 Peking University Medical Information Technology Company Information
  69. 8.12.2 Peking University Medical Information Technology Business Overview
  70. 8.12.3 Peking University Medical Information Technology Hospital Infection Management System Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Peking University Medical Information Technology Hospital Infection Management System Product Portfolio
  72. 8.12.5 Peking University Medical Information Technology Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research